Cure8 news brief
Population estimates help patients understand how common IBD is and show that ulcerative colitis is more common than Crohn’s in this survey. Knowing prevalence and who is more likely to be diagnosed can help people feel less isolated and guide public-health planning and access efforts.
Adults with IBD, people with possible IBD symptoms or newly diagnosed patients, caregivers, gastroenterologists, and policy-makers concerned with access and cost of care.
New federal survey data (NCHS using 2023–2024 NHIS) estimate about 4.1 million U.S. adults have been told they have Crohn’s disease or ulcerative colitis, with ulcerative colitis roughly twice as common as Crohn’s.
The report presents lifetime-diagnosis prevalence (people ever told by a clinician), shows prevalence rises with age, and notes differences by sex and race/ethnicity. The article explains limits of survey-based estimates and contrasts them with claims-based counts.
The piece is a plain-language summary of the NCHS Health E-Stat and does not present new clinical findings or trial data. It highlights practical implications: IBD affects a substantial number of Americans, prevalence estimates vary by data source, and persistent GI symptoms should prompt medical evaluation rather than assuming IBS.
This brief is based on the news article summarizing the NCHS report (survey-based prevalence estimates). It does not represent Cure8 review of underlying data tables beyond what the article reports.
These numbers come from household survey responses (self-report of a clinician diagnosis), so they measure lifetime diagnosis rather than current active disease and can differ from claims-based estimates. The report notes possible undercounting from nonresponse and excludes institutionalized populations.
The article summarizes the NCHS E-Stat rather than presenting new research results.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Personal stories can help people with Crohn’s recognize symptoms that aren’t just diet-related, learn that effective medical treatments (including infusions) exist, and feel less isolated. The article also emphasizes...
Knowing the type of Crohn’s disease helps explain where symptoms come from and what treatments or procedures might be considered. The article links specific symptoms and complications to each anatomical pattern of...
Market reports highlight which companies and drug types are investing in Crohn's disease — that can signal upcoming therapies, trial activity, and availability. Mentions of trials (for example anti‑TL1A) may be of...
